Literature DB >> 16141430

Transcranial ultrasound brain perfusion assessment with a contrast agent-specific imaging mode: results of a two-center trial.

Thilo Hölscher1, Wilko Wilkening, Bogdan Draganski, Saskia H Meves, Jens Eyding, Heinz Voit, Ulrich Bogdahn, Horst Przuntek, Thomas Postert.   

Abstract

BACKGROUND AND
PURPOSE: The purpose of this study was to assess brain perfusion with an ultrasound contrast-specific imaging mode and to prove if the results are comparable between 2 centers using a standardized study protocol.
METHODS: A total of 32 individuals without known cerebrovascular disease were included in the study. Perfusion studies were performed ipsilaterally in an axial diencephalic plane after intravenous administration of 0.75 mL of Optison. Offline time intensity curves (TIC) were generated in different anatomic regions. Both centers used identical study protocols, ultrasound machines, and contrast agent.
RESULTS: In both centers, the comparison of the parameter time to peak intensity (TPI) revealed significantly shorter TPIs in the main vessel structures compared with any parenchymal region of interest (ROI), whereas no significant differences were seen between the parenchymal ROIs. The parameter peak intensity (PI) varied widely interindividually in both centers, whereas the inter-ROI comparison revealed statistical significance (P < 0.05) in most of the cases according to the following pattern: (1) lentiforme nucleus > thalamus and white matter region, (2) thalamus > white matter region, and (3) main vessel > any parenchymal structure. Similar results were achieved in both centers independently.
CONCLUSIONS: The study demonstrates that brain perfusion assessment with an ultrasound contrast-specific imaging mode is comparable between different centers using the same study protocol.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16141430     DOI: 10.1161/01.STR.0000179038.63109.b0

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  9 in total

1.  Assessment of tissue perfusion by contrast-enhanced ultrasound.

Authors:  Emilio Quaia
Journal:  Eur Radiol       Date:  2010-10-07       Impact factor: 5.315

Review 2.  Microbubble ultrasound contrast agents: an update.

Authors:  Emilio Quaia
Journal:  Eur Radiol       Date:  2007-03-10       Impact factor: 5.315

3.  Transcranial contrast-enhanced ultrasonography with Sonazoid in semiquantitative evaluation of brain perfusion.

Authors:  Kozue Saito; Toshiko Hirai; Satoshi Ueno
Journal:  J Med Ultrason (2001)       Date:  2013-02-28       Impact factor: 1.314

4.  Application of a second-generation US contrast agent in infants and children--a European questionnaire-based survey.

Authors:  Michael Riccabona
Journal:  Pediatr Radiol       Date:  2012-10-03

5.  Microbubbles traversing the blood-brain barrier for imaging and therapy.

Authors:  Stephen Meairs; Angelika Alonso; Marc Fatar; Rolf Kern; Michael Hennerici
Journal:  Med Biol Eng Comput       Date:  2009-03-13       Impact factor: 2.602

6.  Pitch-catch phase aberration correction of multiple isoplanatic patches for 3-D transcranial ultrasound imaging.

Authors:  Brooks D Lindsey; Stephen W Smith
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2013-03       Impact factor: 2.725

7.  3-D transcranial ultrasound imaging with bilateral phase aberration correction of multiple isoplanatic patches: a pilot human study with microbubble contrast enhancement.

Authors:  Brooks D Lindsey; Heather A Nicoletto; Ellen R Bennett; Daniel T Laskowitz; Stephen W Smith
Journal:  Ultrasound Med Biol       Date:  2013-11-14       Impact factor: 2.998

8.  Refraction correction in 3D transcranial ultrasound imaging.

Authors:  Brooks D Lindsey; Stephen W Smith
Journal:  Ultrason Imaging       Date:  2014-01       Impact factor: 1.578

Review 9.  Contrast-enhanced ultrasound of the pediatric brain.

Authors:  Misun Hwang; Carol E Barnewolt; Jörg Jüngert; Francesco Prada; Anush Sridharan; Ryne A Didier
Journal:  Pediatr Radiol       Date:  2021-02-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.